
No Longer a Last Resort: ECMO as a Bridge to Lung Transplant
ECMO has long been viewed as a last-resort therapy, especially in transplant settings. But new data shows that with the right infrastructure and team, ECMO can serve as a highly effective bridge to lung transplant—even in patients over 60 or those not yet listed at the time of cannulation. A recent study found no significant difference in survival between patients listed before vs. after ECMO initiation, challenging old norms and validating the “bridge to decision” approach. One-year survival among those transplanted reached 88%, rivaling national averages. The case of Ben Askren, a former MMA fighter who received a double lung transplant after ECMO rescue, underscores this potential. As more hospitals implement full-spectrum ECMO programs, these findings reinforce the life-saving possibilities when time, expertise, and flexibility align.




